Covered recipient · General Payments record
JEFFREY S GOTTFRIED
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,348.74
- Reported across 80 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $332.70 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $89.99 | 5 |
| ABBVIE INC. | $85.80 | 4 |
| Lilly USA, LLC | $68.28 | 4 |
| Amgen Inc. | $64.32 | 4 |
| Exact Sciences Corporation | $24.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.51 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103824502 | CMS |
| ABBVIE INC. | $22.47 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103824504 | CMS |
| ABBVIE INC. | $22.20 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103824506 | CMS |
| ABBVIE INC. | $22.62 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103824508 | CMS |
| Amgen Inc. | $14.72 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117264345 | CMS |
| Amgen Inc. | $14.00 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117264347 | CMS |
| Amgen Inc. | $13.75 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111587632 | CMS |
| Amgen Inc. | $21.85 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117264349 | CMS |
| Exact Sciences Corporation | $24.31 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114680446 | CMS |
| Lilly USA, LLC | $15.60 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135061173 | CMS |
| Lilly USA, LLC | $21.05 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135061175 | CMS |
| Lilly USA, LLC | $16.06 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135040079 | CMS |
| Lilly USA, LLC | $15.57 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135012005 | CMS |
| Novo Nordisk Inc | $21.72 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096937925 | CMS |
| Novo Nordisk Inc | $21.72 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096915536 | CMS |
| Novo Nordisk Inc | $17.31 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097101093 | CMS |
| Novo Nordisk Inc | $13.11 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097820308 | CMS |
| Novo Nordisk Inc | $16.13 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097445134 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.